Academic Journal
Biphasic injection for masseter muscle reduction with botulinum toxin
العنوان: | Biphasic injection for masseter muscle reduction with botulinum toxin |
---|---|
المؤلفون: | Fabrizio Chirico, Pierfrancesco Bove, Romolo Fragola, Angelo Cosenza, Nadia De Falco, Giorgio Lo Giudice, Giovanni Audino, Giuseppe Mario Rauso |
المساهمون: | Chirico, Fabrizio, Bove, Pierfrancesco, Fragola, Romolo, Cosenza, Angelo, De Falco, Nadia, Lo Giudice, Giorgio, Audino, Giovanni, Mario Rauso, Giuseppe |
بيانات النشر: | MDPI AG |
سنة النشر: | 2021 |
المجموعة: | Sapienza Università di Roma: CINECA IRIS |
مصطلحات موضوعية: | masseter muscle hypertrophy, botulinum toxin type A, biphasic injection technique, paradoxical bulging, muscular bulging, non-surgical facial slimming, lower face reshaping, neurotoxic weakening, complication |
الوصف: | Masseter Muscle Hypertrophy (MMH) is a well-known clinical benign condition that is not gender-specific and it can be monolateral or bilateral. Botulinum Toxin type A (BoNTA) injection has been widely described for MMH treatment and non-surgical facial slimming. BoNTA masseter injections have high efficacy and safety profile, but the risks of side effects remain. Muscular bulging during mastication is a complication due to the superficial overcompensation of masseteric fibers in response to neurotoxic weakening of the deep masseter. We present a biphasic-injection technique for BoNTA administration, based following anatomical concept and developed in order to prevent paradoxical bulging. A total of 98 treatments from 2015 to 2020 were performed with this technique. No remarkable complications occurred in our study. No cases of loss of full smile, difficulty in mouth opening, dizziness, headache, neurapraxia, and xerostomia were reported. A case of asymmetric smiling was self-resolved within a week. No patient claimed transient muscle weakness as distressing. No cases of paradoxical bulging were observed. Extensive knowledge of muscular anatomy and appropriate injection technique are key factors in achieving the desired result and avoiding complications. We feel that sharing this tip could be helpful for all the physicians involved in MMH treatment with BoNTA. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
Relation: | info:eu-repo/semantics/altIdentifier/wos/WOS:000675960600001; volume:11; issue:14; journal:APPLIED SCIENCES; https://hdl.handle.net/11573/1695725; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85111134000 |
DOI: | 10.3390/app11146478 |
الاتاحة: | https://hdl.handle.net/11573/1695725 https://doi.org/10.3390/app11146478 |
Rights: | info:eu-repo/semantics/openAccess |
رقم الانضمام: | edsbas.690832F6 |
قاعدة البيانات: | BASE |
DOI: | 10.3390/app11146478 |
---|